N
168.62
3.11 (1.88%)
| Previous Close | 165.51 |
| Open | 169.11 |
| Volume | 3,074,380 |
| Avg. Volume (3M) | 2,031,831 |
| Market Cap | 325,954,306,048 |
| Price / Earnings (TTM) | 23.58 |
| Price / Earnings (Forward) | 17.36 |
| Price / Sales | 5.55 |
| Price / Book | 6.66 |
| 52 Weeks Range | |
| Earnings Date | 28 Apr 2026 |
| TTM Dividend Yield | 2.46% |
| Profit Margin | 24.16% |
| Operating Margin (TTM) | 35.40% |
| Diluted EPS (TTM) | 6.38 |
| Quarterly Revenue Growth (YOY) | 12.40% |
| Quarterly Earnings Growth (YOY) | 34.20% |
| Total Debt/Equity (MRQ) | 81.32% |
| Current Ratio (MRQ) | 0.790 |
| Operating Cash Flow (TTM) | 19.00 B |
| Levered Free Cash Flow (TTM) | 13.89 B |
| Return on Assets (TTM) | 11.42% |
| Return on Equity (TTM) | 32.89% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - General (US) | Bullish | Mixed |
| Drug Manufacturers - General (Global) | Bullish | Mixed | |
| Stock | Novartis AG | Mixed | Bearish |
AIStockmoo Score
0.3
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -3.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 0.5 |
| Average | 0.25 |
|
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Investment Style | Large Core |
| % Held by Institutions | 7.16% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 20 Feb 2026 | CNBC | With Trump's 'reciprocal' tariffs struck down, here are the industries still facing higher rates |
| 06 Feb 2026 | Announcement | Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery |
| 09 Jan 2026 | Announcement | Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment |
| 19 Dec 2025 | CNBC | Nine of the largest pharma companies ink deals with Trump to lower drug prices |
| 12 Dec 2025 | Announcement | Novartis breaks ground on flagship manufacturing hub in North Carolina |
| TTM Dividend Yield | 2.46% |
| 5Y Average Dividend Yield | 2.15% |
| Payout Ratio | 62.60% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 12 Mar 2025 | 20 Feb 2025 | - | 3.869541 Cash |
| 09 Mar 2023 | 02 Feb 2023 | 20 Mar 2023 | 3.4693612 Cash |
| 08 Mar 2022 | 03 Feb 2022 | 17 Mar 2022 | 3.3252497 Cash |
| 04 Mar 2021 | 26 Jan 2021 | 15 Mar 2021 | 3.1990725 Cash |
| 03 Mar 2020 | 31 Jan 2020 | 12 Mar 2020 | 3.0873655 Cash |
| 04 Mar 2019 | 31 Jan 2019 | 13 Mar 2019 | 2.834128 Cash |
| 06 Mar 2018 | 07 Mar 2018 | 25 Apr 2018 | 2.936451 Cash |
| 01 Mar 2017 | - | 20 Apr 2017 | 2.717759 Cash |
| 24 Feb 2016 | - | 15 Apr 2016 | 2.717946 Cash |
| 02 Mar 2015 | - | 20 Apr 2015 | 2.665947 Cash |
| 27 Feb 2014 | - | 10 Apr 2014 | 2.759789 Cash |
| 26 Feb 2013 | - | 05 Apr 2013 | 2.42647 Cash |
| 27 Feb 2012 | - | 05 Apr 2012 | 2.482145 Cash |
| 24 Feb 2011 | - | 08 Apr 2011 | 2.36336 Cash |
| 02 Mar 2010 | - | 13 Apr 2010 | 1.948359 Cash |
| 24 Feb 2009 | - | 06 Apr 2009 | 1.714383 Cash |
| 26 Feb 2008 | - | 11 Apr 2008 | 1.537471 Cash |
| 06 Mar 2007 | - | 10 Apr 2007 | 1.096517 Cash |
| 28 Feb 2006 | - | 03 Apr 2006 | 0.880052 Cash |
| 01 Mar 2005 | - | 06 Apr 2005 | 0.88322 Cash |
| 24 Feb 2004 | - | 30 Mar 2004 | 0.78117 Cash |
| 04 Mar 2003 | - | 07 Apr 2003 | 0.70553 Cash |
| 21 Mar 2002 | - | 22 Apr 2002 | 0.4557 Cash |
| 22 Mar 2001 | - | 20 Apr 2001 | 0.4213 Cash |
| 12 Apr 2000 | - | 11 May 2000 | 0.8195 Cash |
| 21 Apr 1999 | - | 24 May 1999 | 0.8097 Cash |
| 21 Apr 1998 | - | 19 May 1998 | 0.7109 Cash |
| 16 Apr 1997 | - | 15 May 1997 | 0.5785 Cash |
| 26 Feb 1997 | - | 19 Mar 1997 | 3.234 Cash |
| 17 Apr 1996 | - | 16 May 1996 | 0.5156 Cash |
| 01 May 1995 | - | 31 May 1995 | 0.418 Cash |
| Show more | |||
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2023 | 3.47 | 1 | 3.44 |
| 2022 | 3.33 | 1 | 3.67 |
| 2021 | 3.20 | 1 | 3.66 |
| 2020 | 3.09 | 1 | 3.27 |
| 2019 | 2.83 | 1 | 2.99 |
| 2018 | 2.94 | 1 | 3.82 |
| 2017 | 2.72 | 1 | 3.61 |
| 2016 | 2.72 | 1 | 4.16 |
| 2015 | 2.67 | 1 | 3.46 |
| 2014 | 2.76 | 1 | 3.32 |
| 2013 | 2.43 | 1 | 3.37 |
| 2012 | 2.48 | 1 | 4.38 |
| 2011 | 2.36 | 1 | 4.61 |
| 2010 | 1.95 | 1 | 3.69 |
| 2009 | 1.71 | 1 | 3.52 |
| 2008 | 1.54 | 1 | 3.45 |
| 2007 | 1.10 | 1 | 2.25 |
| 2006 | 0.880 | 1 | 1.71 |
| 2005 | 0.883 | 1 | 1.88 |
| 2004 | 0.781 | 1 | 1.73 |
| 2003 | 0.706 | 1 | 1.72 |
| 2002 | 0.456 | 1 | 1.39 |
| 2001 | 0.421 | 1 | 1.29 |
| 2000 | 0.820 | 1 | 2.04 |
| 1999 | 0.810 | 1 | 2.47 |
| 1998 | 0.711 | 1 | 1.62 |
| 1997 | 3.81 | 2 | 10.46 |
| 1996 | 0.516 | 1 | 2.00 |
| Show more | |||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |